BioCentury
ARTICLE | Financial News

Vivo Capital closes new early stage fund

June 14, 2016 1:14 AM UTC

Vivo Capital closed its new Vivo Panda fund with more than $100 million to invest primarily in early stage healthcare companies, including biotech, medtech and diagnostics. ...